Stocks tumbled after President Trump escalated his trade war against the rest of the world. But rather than scooping up ...
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now
President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...
That's why Veeva Systems should remain a leader in its niche and deliver excellent returns over the long run. It's a top stock to buy and hold for the next two decades.
We recently published a list of 10 Best Beaten Down Stocks to Buy According to Analysts. In this article, we are going to ...
Novo Nordisk revealed a stunning increase in pollution amid plans to boost production of its popular weight loss drug Wegovy.
Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These ...
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...
President Trump has announced sweeping tariffs on several countries. Novo Nordisk and Smith & Nephew may be the most at risk ...
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results